For a number of years I have been involved on the editorial board of the Springer journal Pharmaceutical Research (current IF 4.7). In full disclosure I receive a small stipend each year for my editorial role and I attend one editorial board meeting per year. I am the only person not from an academic institute …
Category Archive: publishing
Mar
21
Mar
10
Paying to see conference abstracts for a rare disease conference..
I was updating my CV and realized that a couple of abstracts submitted for the World Symposium (on lysosomal diseases) in 2013 and 2014 are published in Molecular Genetics and Metabolism. This year there were 282 such abstracts published and I know that because I along with every attendee could take home a copy of …
Jan
14
A yearbook of science
A pleasant surprise awaited my return home yesterday, a large envelope from the published McGraw-Hill. Inside was a The McGraw-Hill yearbook of science and technology 2014 . It took a few minutes to remember that I was a contributor to a section. And then I found the article – Below is the official reference. Grulke …
Dec
30
Journal editors add more balance than needed – provides marketing windfall
Just when you think the year is going to end without having to get drawn into some additional discussion on publishing.. well it happens.. I get an email today that the article a (very nice) journalist, Vivien Marx had written for Nature Methods “Pouring over liquid handling” was now published. Lets get this straight at …
Dec
30
Summary of collaborative publications in 2013.
Time for a brief end of year summary and some insights into various papers, reviews and commentaries I was involved in this year. I have probably missed a few papers that are either not in PubMed or come to mind readily so will likely add as I remember them. What really struck me in a …
Sep
05
Rare disease heroes – Extraordinary collaborators we should be listening too
Sometimes you meet people that truly inspire you to do more, question what you have been doing and rethink your goals in life. But when you meet three of them in a short space of time you realize that something transformative is happening. In the space of two years three non-scientists have overtaken all my …
Aug
06
Being paid to publish in journals- an incentive?
[Right up front I will remind you of any potential conflicts of interest as I am on the editorial board of Pharmaceutical Research (Springer), Drug Discovery Today (Elsevier), Mutation Research Reviews (Elsevier), Journal of Pharmacological and Toxicological Methods (Elsevier) and Chem-Bio Informatics (Chem-Bio Informatics Society).] Barely a day goes by without having to cleanse my …
Jul
22
Data Accessibility in the 21st Century
I was reminded at the weekend that there are are accessible scientists and there is accessible data and occasionally both. I recently had a reprint request for a paper I co-authored in 1999 and a dataset request for a paper published in 2010. I took time out of my weekend to respond to both scientists …
Jun
27
Missing citations and papers relating to the Malaria screening public datasets
Just catching up on some reading and I caught the nice paper on the MalariaBox in PLOSONE which describes the molecular property profiling and filtering of 3 sets of compounds screened by groups at GSK, Novartis and St Jude . The readers of this paper may be interested in work not cited that also discusses …
Jun
03
Politics, Science and publishing
I just had the following email from Elsevier, I am sure it will be coming to other journal editors and editorial board members from other publishers too… As a scientist I am deeply saddened to see high level government politics coming into play when it comes to saying who can and cannot publish in …